Shandong Wohua Pharmaceutical Co Ltd (002107) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shandong Wohua Pharmaceutical Co Ltd (002107) has a cash flow conversion efficiency ratio of 0.036x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥27.12 Million ≈ $3.97 Million USD) by net assets (CN¥760.19 Million ≈ $111.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002107 net asset quality index to measure how much of total assets are equity-financed.
Shandong Wohua Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Shandong Wohua Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Shandong Wohua Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Shandong Wohua Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Wohua Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Value Grupo Financiero S.A.B. de C.V
MX:VALUEGFO
|
0.102x |
|
Henan Newland Pharmaceutical Co. Ltd. A
SHE:301277
|
N/A |
|
AvenuesAI Limited
NSE:INFIBEAM
|
0.075x |
|
London Stock Exchange Group PLC
LSE:LSEG
|
0.064x |
|
Semco Technologies Sas
PA:ALSEM
|
N/A |
|
Jiangxi Tianli Technology INC
SHE:300399
|
-0.072x |
|
Northrim BanCorp Inc
NASDAQ:NRIM
|
0.081x |
|
VinaCapital Vietnam Opportunity Fund
LSE:VOF
|
0.062x |
Annual Cash Flow Conversion Efficiency for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Shandong Wohua Pharmaceutical Co Ltd from 2003 to 2025. For the full company profile with market capitalisation and key ratios, see Shandong Wohua Pharmaceutical Co Ltd stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥720.90 Million ≈ $105.49 Million |
CN¥128.53 Million ≈ $18.81 Million |
0.178x | +40.85% |
| 2024-12-31 | CN¥722.93 Million ≈ $105.79 Million |
CN¥91.51 Million ≈ $13.39 Million |
0.127x | -18.37% |
| 2023-12-31 | CN¥833.48 Million ≈ $121.96 Million |
CN¥129.25 Million ≈ $18.91 Million |
0.155x | -33.89% |
| 2022-12-31 | CN¥789.79 Million ≈ $115.57 Million |
CN¥185.26 Million ≈ $27.11 Million |
0.235x | +8.92% |
| 2021-12-31 | CN¥929.26 Million ≈ $135.98 Million |
CN¥200.12 Million ≈ $29.28 Million |
0.215x | +0.57% |
| 2020-12-31 | CN¥918.01 Million ≈ $134.33 Million |
CN¥196.58 Million ≈ $28.77 Million |
0.214x | +424.35% |
| 2019-12-31 | CN¥775.15 Million ≈ $113.43 Million |
CN¥31.66 Million ≈ $4.63 Million |
0.041x | -73.66% |
| 2018-12-31 | CN¥695.78 Million ≈ $101.81 Million |
CN¥107.88 Million ≈ $15.79 Million |
0.155x | -17.92% |
| 2017-12-31 | CN¥655.78 Million ≈ $95.96 Million |
CN¥123.88 Million ≈ $18.13 Million |
0.189x | +48.37% |
| 2016-12-31 | CN¥572.64 Million ≈ $83.79 Million |
CN¥72.91 Million ≈ $10.67 Million |
0.127x | -47.54% |
| 2015-12-31 | CN¥547.26 Million ≈ $80.08 Million |
CN¥132.82 Million ≈ $19.44 Million |
0.243x | +476.90% |
| 2014-12-31 | CN¥631.74 Million ≈ $92.44 Million |
CN¥26.58 Million ≈ $3.89 Million |
0.042x | +67.96% |
| 2013-12-31 | CN¥605.04 Million ≈ $88.54 Million |
CN¥15.15 Million ≈ $2.22 Million |
0.025x | -56.03% |
| 2012-12-31 | CN¥594.41 Million ≈ $86.98 Million |
CN¥33.86 Million ≈ $4.95 Million |
0.057x | +2351.16% |
| 2011-12-31 | CN¥586.07 Million ≈ $85.76 Million |
CN¥1.36 Million ≈ $199.29K |
0.002x | +108.98% |
| 2010-12-31 | CN¥590.64 Million ≈ $86.43 Million |
CN¥-15.28 Million ≈ $-2.24 Million |
-0.026x | +16.14% |
| 2009-12-31 | CN¥688.45 Million ≈ $100.74 Million |
CN¥-21.24 Million ≈ $-3.11 Million |
-0.031x | -155.30% |
| 2008-12-31 | CN¥637.88 Million ≈ $93.34 Million |
CN¥35.59 Million ≈ $5.21 Million |
0.056x | +82.60% |
| 2007-12-31 | CN¥342.22 Million ≈ $50.08 Million |
CN¥10.46 Million ≈ $1.53 Million |
0.031x | -90.54% |
| 2006-12-31 | CN¥142.57 Million ≈ $20.86 Million |
CN¥46.05 Million ≈ $6.74 Million |
0.323x | +175.75% |
| 2005-12-31 | CN¥111.06 Million ≈ $16.25 Million |
CN¥13.01 Million ≈ $1.90 Million |
0.117x | -71.34% |
| 2004-12-31 | CN¥82.62 Million ≈ $12.09 Million |
CN¥33.77 Million ≈ $4.94 Million |
0.409x | +16.24% |
| 2003-12-31 | CN¥51.69 Million ≈ $7.56 Million |
CN¥18.17 Million ≈ $2.66 Million |
0.352x | -- |
About Shandong Wohua Pharmaceutical Co Ltd
Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, oral liquid, and pills; medicinal herb cultivation; and provides pharmaceutical technology consulting services. It also offers products including drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu t… Read more